例如:"NBL1", "4681", "drought"
收藏
4605 MYBL2

4605

MYBL2

MYB proto-oncogene like 2

protein-coding

Homo sapiens

基因描述

Type Description
Definition MYB proto-oncogene like 2

研究结论

Date Results Publications
2021-02-06 13:50:00 LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2. 31758653
2021-02-02 13:27:00 B-MYB-p53-related relevant regulator for the progression of clear cell renal cell carcinoma. 32951068
2021-01-23 13:02:00 MYBL2 amplification in breast cancer: Molecular mechanisms and therapeutic potential. 32853735
2021-01-16 15:54:00 Characterization of the zinc finger proteins ZMYM2 and ZMYM4 as novel B-MYB binding proteins. 32439918
2020-11-28 13:12:00 Overexpression of MYBL2 promotes proliferation and migration of non-small-cell lung cancer via upregulating NCAPH. 32200471

名称对应

Type IDs
Synonymous B-MYB, BMYB
Gene
UniProtKB-ID: MYBB_HUMAN
UniprotKB: P10244
UniParc: UPI0002065802, UPI000012FAE1
EMBL: X13293, AK223482, AK303249, AK314791, AL121886, BC007585, CH471077, BC053555
Ensembl: ENSG00000101057
KO: hsa:4605
Nucleutide sequences
EMBL-CDS: BAG37322.1, AAH53555.1, EAW75951.1, BAH13925.1, BAD97202.1, AAH07585.1, CAA31655.1
Ensembl_TRS: ENST00000396863, ENST00000217026
Protein sequencees
Ensembl_PRO: ENSP00000380072, ENSP00000217026
RefSeq: NP_002457.1, NP_001265539.1
Others
UniRef100: UniRef100_P10244
UniRef90: UniRef90_P10244
UniRef50: UniRef50_P10244
UniGene: Hs.179718
CCDS: CCDS13322.1, CCDS63276.1

全选

{{proteinIndex+1}}
mRNA Protein UniprotKB Description
Refseq {{protein.nucleotideVersion}}

Ensembl: {{protein.nucleotideEnsembl}}

{{protein.proteinVersion}}

Ensembl: {{protein.proteinEnsembl}}

{{uniprot}}
Definition: {{{protein.definition}}}

Transcript Veriant:{{protein.transcriptVeriant}}

Status: {{protein.status}}

Location ( {{protein.positionStart}}..{{protein.positionEnd}} )

暂无数据

研究热度

热点单位
排名 科研单位 文献
{{affIndex+1}}

{{aff.value}}

{{aff.size}}

目前还没有研究热点单位

热点人员
排名 研究人员 文献
{{authorIndex+1}}

{{author.value}}

{{author.size}}

目前还没有研究热点人员